blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3357494

EP3357494 - THERAPEUTIC AGENT AND/OR PROPHYLACTIC AGENT FOR PERIPHERAL NERVE DISORDER OR SPINAL INJURY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  28.07.2023
Database last updated on 07.10.2024
FormerExamination is in progress
Status updated on  05.03.2021
FormerRequest for examination was made
Status updated on  06.07.2018
FormerThe international publication has been made
Status updated on  08.04.2017
Most recent event   Tooltip28.07.2023Application deemed to be withdrawnpublished on 30.08.2023  [2023/35]
Applicant(s)For all designated states
National University Corporation Nagoya University
1, Furo-cho
Chikusa-ku
Nagoya-shi, Aichi 464-8601 / JP
For all designated states
Sumitomo Dainippon Pharma Co., Ltd.
6-8, Dosho-machi 2-chome
Chuo-ku
Osaka-shi
Osaka 541-8524 / JP
[2018/32]
Inventor(s)01 / OHNO, Kinji
c/o NATIONAL UNIVERSITY CORPORATION NAGOYA
UNIVERSITY
1 Furo-cho
Chikusa-ku
Nagoya-shi Aichi 464-8601 / JP
02 / ISHIGURO, Naoki
c/o NATIONAL UNIVERSITY CORPORATION NAGOYA
UNIVERSITY
1 Furo-cho
Chikusa-ku
Nagoya-shi Aichi 464-8601 / JP
03 / OKAWARA, Bisei
c/o NATIONAL UNIVERSITY CORPORATION NAGOYA
UNIVERSITY
1 Furo-cho
Chikusa-ku
Nagoya-shi Aichi 464-8601 / JP
04 / YAGI, Hideki
c/o Japanese Red Cross Nagoya Daiichi Hospital
35, Michishita-cho, 3-chome
Nakamura-ku
Nagoya-city, Aichi 453-8511 / JP
05 / OTA, Kyotaro
c/o NATIONAL UNIVERSITY CORPORATION NAGOYA
UNIVERSITY
1 Furo-cho
Chikusa-ku
Nagoya-shi Aichi 464-8601 / JP
 [2018/32]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2018/32]
Application number, filing date16851733.229.09.2016
[2018/32]
WO2016JP78801
Priority number, dateJP2015019329130.09.2015         Original published format: JP 2015193291
[2018/32]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017057562
Date:06.04.2017
Language:JA
[2017/14]
Type: A1 Application with search report 
No.:EP3357494
Date:08.08.2018
Language:EN
[2018/32]
Search report(s)International search report - published on:JP06.04.2017
(Supplementary) European search report - dispatched on:EP25.04.2019
ClassificationIPC:A61K31/423, A61P1/08, A61P1/10, A61P1/12, A61P9/00, A61P19/00, A61P19/02, A61P21/00, A61P21/02, A61P25/02, A61P29/00
[2018/32]
CPC:
A61K31/423 (EP,US); A61P25/02 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/32]
TitleGerman:THERAPEUTISCHER WIRKSTOFF UND/ODER PROPHYLAKTISCHER WIRKSTOFF FÜR PERIPHERE NERVENSTÖRUNG ODER WIRBELSÄULENVERLETZUNGEN[2018/32]
English:THERAPEUTIC AGENT AND/OR PROPHYLACTIC AGENT FOR PERIPHERAL NERVE DISORDER OR SPINAL INJURY[2018/32]
French:AGENT THÉRAPEUTIQUE ET/OU AGENT PROPHYLACTIQUE POUR UN TROUBLE DES NERFS PÉRIPHÉRIQUES OU UNE LÉSION SPINALE[2018/32]
Entry into regional phase28.03.2018Translation filed 
28.03.2018National basic fee paid 
28.03.2018Search fee paid 
28.03.2018Designation fee(s) paid 
28.03.2018Examination fee paid 
Examination procedure28.03.2018Examination requested  [2018/32]
28.03.2018Date on which the examining division has become responsible
17.07.2019Amendment by applicant (claims and/or description)
09.03.2021Despatch of a communication from the examining division (Time limit: M06)
17.09.2021Reply to a communication from the examining division
01.04.2023Application deemed to be withdrawn, date of legal effect  [2023/35]
25.04.2023Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2023/35]
Fees paidRenewal fee
24.09.2018Renewal fee patent year 03
24.09.2019Renewal fee patent year 04
23.09.2020Renewal fee patent year 05
23.09.2021Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.09.202207   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2004024096  (ELAN PHARM INC [US], et al) [X] 1-12 * page 6; claim - *;
 [X]  - B Battista, "Zonisamide administration for the treatment of diabetic peripheral neuropathy: Safety and efficacy", (20080101), URL: https://journals.lww.com/ejanaesthesiology/Fulltext/2008/05001/Zonisamide_administration_for_the_treatment_of.679.aspx#pdf-link, (20190415), XP055580915 [X] 1-12 * abstract *

DOI:   http://dx.doi.org/10.1097/00003643-200805001-00679
 [X]  - SONYA J. SNEDECOR ET AL, "Systematic Review and Meta-Analysis of Pharmacological Therapies for Painful Diabetic Peripheral Neuropathy", PAIN PRACTICE, US, (20130328), vol. 14, no. 2, doi:10.1111/papr.12054, ISSN 1530-7085, pages 167 - 184, XP055580902 [X] 1-12 * page 177 - page 178; figure 3 *

DOI:   http://dx.doi.org/10.1111/papr.12054
 [X]  - Aysel Atli ET AL, "PA I N M E D I C I N E Volume 6 @BULLET Number 3 @BULLET 2005 Zonisamide in the Treatment of Painful Diabetic NeuropathyAtli and Dogra Zonisamide in the Treatment of Painful Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Pilot Study", (20050101), URL: https://academic.oup.com/painmedicine/article-pdf/6/3/225/5199718/6-3-225.pdf, (20190415), XP055580894 [X] 1-12 * page 232 *
 [X]  - BACKONJA M-M, "USE OF ANTICONVULSANTS FOR TREATMENT OF NEUROPATHIC PAIN", NEURO, LIPPINCOTT WILLIAMS & WILKINS, PHILADELPHIA, US, (20020910), vol. 59, no. 5, SUPPL. 02, ISSN 0028-3878, pages S14 - S17, XP009042844 [X] 1-12 * page s16 *
International search[X]JP2010527965  (Neurosearch A/S) [X] 1-7 * , claims 7, 13 & US 2010/0168192 A1 & WO 2008/142134 A1 claims 7, 13 & EP 2152679 A1 *;
 [Y]WO9933465  (DAINIPPON PHARMACEUTICAL CO [JP], et al) [Y] 1-7 * , claims 1, 6; table 7 & US 6342515 B1 & EP 1040830 A1 paragraph [0022]; claims 1, 6 *;
 [Y]JP2003012523  (OTSUKA YAKUHIN KOGYO KK) [Y] 1-7 * , paragraph [0003] (Family: none) *
 [X]  - TAKEHISA HIRAYAMA et al., "Wobbler Mouse no Sekizui Undo Neuron Shogai ni Taisuru zonisamide Ryoho no Kento", Neurological Therapeutics, (20120925), vol. 29, no. 5, page 670, XP 009509372 [X] 1-5 * , column of 3D-12 *
 [X]  - M TANABE et al., "Centrally mediated antihyperalgesic and antiallodynic effects of zonisamide following partial nerve injury in the mouse", Naunyn-Schmiedeberg's Arch Pharmacol, (20050000), vol. 372, pages 107 - 114, XP 019326097 [X] 1, 2, 6
 [X]  - MASANOBU UCHIGATA, "Parkinson-byo Choki Chiryorei eno Zonisamide Tsuika Toyo ni yori, Shojo no Kaizen ga Erareta Ichi Shorei", Pharma Med, (20120410), vol. 30, no. 4, pages 85 - 88, XP009510119 [X] 1-3, 7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.